BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28232660)

  • 1. Clinical Impact of Liver Biopsies in Liver Transplant Recipients.
    Voigtländer T; Alten TA; Kirstein MM; Lehner F; Manns MP; Schlué J; Wedemeyer H; Lankisch TO
    Ann Transplant; 2017 Feb; 22():108-114. PubMed ID: 28232660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular profiling of subclinical inflammatory lesions in long-term surviving adult liver transplant recipients.
    Londoño MC; Souza LN; Lozano JJ; Miquel R; Abraldes JG; Llovet LP; Quaglia A; Rimola A; Navasa M; Sánchez-Fueyo A
    J Hepatol; 2018 Sep; 69(3):626-634. PubMed ID: 29709679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
    Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.
    Stravitz RT; Shiffman ML; Sanyal AJ; Luketic VA; Sterling RK; Heuman DM; Ashworth A; Mills AS; Contos M; Cotterell AH; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2004 Jul; 10(7):850-8. PubMed ID: 15237368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value and safety of liver biopsies in patients transplanted for hepatitis C virus-related end-stage liver disease.
    Brauner C; Lankisch TO; Fytili P; Jaroszewicz J; Lehner F; Barg-Hock H; Klempnauer J; Jaeckel E; Manns MP; Wedemeyer H; Negm AA
    Transpl Infect Dis; 2014 Dec; 16(6):958-67. PubMed ID: 25393916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Charlton M; Seaberg E
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of hepatitis C viral RNA levels in liver tissue to distinguish rejection from recurrent hepatitis C.
    Gottschlich MJ; Aardema KL; Burd EM; Nakhleh RE; Brown KA; Abouljoud MS; Hirst K; Moonka DK
    Liver Transpl; 2001 May; 7(5):436-41. PubMed ID: 11349265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of hepatic histopathology in kidney transplant recipients with chronic hepatitis C virus infection and effect of immunosuppression on the course of hepatitis C virus infection.
    Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Selçuk H; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():159-64. PubMed ID: 25894147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are posttransplantation protocol liver biopsies useful in the long term?
    Berenguer M; Rayón JM; Prieto M; Aguilera V; Nicolás D; Ortiz V; Carrasco D; López-Andujar R; Mir J; Berenguer J
    Liver Transpl; 2001 Sep; 7(9):790-6. PubMed ID: 11552213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid minimization in liver transplant recipients: impact on hepatitis C recurrence and post-transplant diabetes.
    Humar A; Crotteau S; Gruessner A; Kandaswamy R; Gruessner R; Payne W; Lake J
    Clin Transplant; 2007; 21(4):526-31. PubMed ID: 17645714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-term liver graft and protocol biopsy: do we want to look? What will we find?
    Ekong UD
    Curr Opin Organ Transplant; 2011 Oct; 16(5):505-8. PubMed ID: 21836515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-mediated rejection in pediatric liver transplant recipients.
    Markiewicz-Kijewska M; Kaliciński P; Kluge P; Piątosa B; Rękawek A; Jankowska I; Kostecka E; Kurowski PN
    Ann Transplant; 2014 Mar; 19():119-23. PubMed ID: 24594760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretransplant Psychosocial Risk Factors May Not Predict Late Nonadherence and Graft Rejection in Adult Liver Transplant Recipients.
    Lieber SR; Helcer J; Leven E; Knight CS; Wlodarkiewicz C; Shenoy A; Shemesh E; Florman SS; Schiano TD; Annunziato RA
    Exp Clin Transplant; 2018 Oct; 16(5):533-540. PubMed ID: 28969524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. US-guided percutaneous liver biopsy in pediatric liver transplant recipients.
    Mandal S; Miraglia R; Maruzzelli L; Liotta R; Tuzzolino F; Spada M; Riva S; Luca A
    J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):756-61. PubMed ID: 24509302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial.
    Neuhaus P; Clavien PA; Kittur D; Salizzoni M; Rimola A; Abeywickrama K; Ortmann E; Chodoff L; Hall M; Korn A; Nashan B;
    Liver Transpl; 2002 Feb; 8(2):132-42. PubMed ID: 11862589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fate of C4d positive kidney allografts lacking histological signs of acute rejection.
    Dickenmann M; Steiger J; Descoeudres B; Mihatsch M; Nickeleit V
    Clin Nephrol; 2006 Mar; 65(3):173-9. PubMed ID: 16550748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis.
    Samonakis DN; Mela M; Quaglia A; Triantos CK; Thalheimer U; Leandro G; Pesci A; Raimondo ML; Dhillon AP; Rolles K; Davidson BR; Patch DW; Burroughs AK
    Transpl Infect Dis; 2006 Mar; 8(1):3-12. PubMed ID: 16623815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late protocol liver biopsies in the liver allograft: a neglected investigation?
    Mells G; Mann C; Hubscher S; Neuberger J
    Liver Transpl; 2009 Aug; 15(8):931-8. PubMed ID: 19642126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.